ClinConnect ClinConnect Logo
Search / Trial NCT03395509

The Intersectional Viborg Screening Program: Cost-(Effectiveness) of Screening for Diabetes and Cardiovascular Diseases

Launched by CENTRAL JUTLAND REGIONAL HOSPITAL · Jan 9, 2018

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Mass Screening Cardiovascular Disease Diabetes

ClinConnect Summary

Description of the cohort: All Viborg municipality citizen are invited to the combined screening program around there 67th birthday. Participants with positive screening results are offered following up consultations and prophylactic interventions are initiated (secondary medical prophylaxis, smoking cessation, introduction to nutritionally deficient diet etc.)

67 years-old citizens from the surrounding municipalities without the offer of the combined screening are used as a control group (1 case: 5 controls).

There are no exclusion criteria.

The screening examination includes: Blood pre...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All Viborg municipality citizen are invited to the combined screening program around there 67th birthday.
  • Exclusion Criteria:
  • There are no exclusion criteria.

About Central Jutland Regional Hospital

Central Jutland Regional Hospital is a leading healthcare institution in Denmark, dedicated to advancing medical research and patient care through innovative clinical trials. As a prominent sponsor of clinical studies, the hospital focuses on enhancing treatment outcomes across various medical fields, leveraging its state-of-the-art facilities and multidisciplinary expertise. Committed to ethical standards and patient safety, Central Jutland Regional Hospital collaborates with a network of healthcare professionals and researchers to contribute to the global body of medical knowledge and improve healthcare delivery for the communities it serves.

Locations

Viborg, , Denmark

Patients applied

0 patients applied

Trial Officials

Annette Høgh, MD, PhD

Study Chair

Steering Committee

Marie Dahl, MSc(nurse)

Study Director

Steering Committee

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials